Zhejiang Medicine Co Ltd Cash Flow Conversion Efficiency
Zhejiang Medicine Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Zhejiang Medicine Co Ltd (600216) has a cash flow conversion efficiency ratio of 0.062x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥690.77 Million ≈ $101.08 Million USD) by net assets (CN¥11.21 Billion ≈ $1.64 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Zhejiang Medicine Co Ltd (1998–2025)
Cash flow conversion efficiency of Zhejiang Medicine Co Ltd from 1998 to 2025. This chart illustrates how Zhejiang Medicine Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View current stock price of Zhejiang Medicine Co Ltd for real-time trading data and today's change.
Zhejiang Medicine Co Ltd Cash Flow Conversion Ratio Explained
Zhejiang Medicine Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Zhejiang Medicine Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Zhejiang Medicine Co Ltd ranked by their cash flow conversion efficiency. Also see 600216 stock market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Edifier Technology Co Ltd
SHE:002351
|
0.051x |
|
Aluar Aluminio Argentino
BA:ALUA
|
0.051x |
|
ELECTROLUX B ADR/2 SK 5
F:ELXA
|
-0.516x |
|
Century Communities Inc
NYSE:CCS
|
-0.018x |
|
Cimpress plc
F:3UF
|
-0.277x |
|
Semrush Holdings Inc
NYSE:SEMR
|
0.051x |
|
Beijing Jiuzhou Yi Gui Environmental Technology Co. Ltd.
SHG:688485
|
N/A |
|
Ruentex Engineering & Construction Co Ltd
TW:2597
|
-0.059x |
Annual Cash Flow Conversion Efficiency for Zhejiang Medicine Co Ltd (1998–2025)
The table below shows the annual cash flow conversion efficiency of Zhejiang Medicine Co Ltd from 1998 to 2025. Review Zhejiang Medicine Co Ltd free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥11.09 Billion ≈ $1.62 Billion |
CN¥1.89 Billion ≈ $275.95 Million |
0.170x | +51.08% |
| 2024-12-31 | CN¥10.87 Billion ≈ $1.59 Billion |
CN¥1.22 Billion ≈ $179.01 Million |
0.113x | +77.21% |
| 2023-12-31 | CN¥9.99 Billion ≈ $1.46 Billion |
CN¥634.31 Million ≈ $92.82 Million |
0.064x | +18.47% |
| 2022-12-31 | CN¥9.71 Billion ≈ $1.42 Billion |
CN¥520.60 Million ≈ $76.18 Million |
0.054x | -56.69% |
| 2021-12-31 | CN¥9.18 Billion ≈ $1.34 Billion |
CN¥1.14 Billion ≈ $166.33 Million |
0.124x | -20.90% |
| 2020-12-31 | CN¥8.03 Billion ≈ $1.18 Billion |
CN¥1.26 Billion ≈ $183.90 Million |
0.157x | +188.76% |
| 2019-12-31 | CN¥8.25 Billion ≈ $1.21 Billion |
CN¥447.25 Million ≈ $65.45 Million |
0.054x | -24.45% |
| 2018-12-31 | CN¥8.08 Billion ≈ $1.18 Billion |
CN¥579.91 Million ≈ $84.86 Million |
0.072x | +10.84% |
| 2017-12-31 | CN¥7.78 Billion ≈ $1.14 Billion |
CN¥503.47 Million ≈ $73.67 Million |
0.065x | +34.62% |
| 2016-12-31 | CN¥6.99 Billion ≈ $1.02 Billion |
CN¥336.14 Million ≈ $49.19 Million |
0.048x | +198.51% |
| 2015-12-31 | CN¥6.62 Billion ≈ $968.00 Million |
CN¥106.54 Million ≈ $15.59 Million |
0.016x | -80.78% |
| 2014-12-31 | CN¥6.56 Billion ≈ $960.18 Million |
CN¥549.90 Million ≈ $80.47 Million |
0.084x | -17.10% |
| 2013-12-31 | CN¥6.48 Billion ≈ $948.29 Million |
CN¥655.09 Million ≈ $95.86 Million |
0.101x | -22.42% |
| 2012-12-31 | CN¥6.20 Billion ≈ $906.81 Million |
CN¥807.49 Million ≈ $118.16 Million |
0.130x | -37.18% |
| 2011-12-31 | CN¥4.40 Billion ≈ $643.92 Million |
CN¥912.75 Million ≈ $133.56 Million |
0.207x | -39.12% |
| 2010-12-31 | CN¥3.86 Billion ≈ $565.33 Million |
CN¥1.32 Billion ≈ $192.62 Million |
0.341x | -33.46% |
| 2009-12-31 | CN¥2.86 Billion ≈ $418.70 Million |
CN¥1.47 Billion ≈ $214.39 Million |
0.512x | -22.67% |
| 2008-12-31 | CN¥1.81 Billion ≈ $265.19 Million |
CN¥1.20 Billion ≈ $175.59 Million |
0.662x | +154.11% |
| 2007-12-31 | CN¥873.73 Million ≈ $127.85 Million |
CN¥227.67 Million ≈ $33.32 Million |
0.261x | +19.49% |
| 2006-12-31 | CN¥777.31 Million ≈ $113.74 Million |
CN¥169.51 Million ≈ $24.80 Million |
0.218x | +535.06% |
| 2005-12-31 | CN¥732.23 Million ≈ $107.15 Million |
CN¥25.14 Million ≈ $3.68 Million |
0.034x | -79.39% |
| 2004-12-31 | CN¥645.68 Million ≈ $94.48 Million |
CN¥107.60 Million ≈ $15.75 Million |
0.167x | +58.20% |
| 2003-12-31 | CN¥628.48 Million ≈ $91.97 Million |
CN¥66.20 Million ≈ $9.69 Million |
0.105x | +186.82% |
| 2002-12-31 | CN¥629.71 Million ≈ $92.15 Million |
CN¥23.13 Million ≈ $3.38 Million |
0.037x | -77.25% |
| 2001-12-31 | CN¥608.50 Million ≈ $89.04 Million |
CN¥98.25 Million ≈ $14.38 Million |
0.161x | +868.83% |
| 2000-12-31 | CN¥635.03 Million ≈ $92.92 Million |
CN¥10.58 Million ≈ $1.55 Million |
0.017x | +120.07% |
| 1999-12-31 | CN¥625.07 Million ≈ $91.47 Million |
CN¥-51.90 Million ≈ $-7.60 Million |
-0.083x | -150.15% |
| 1998-12-31 | CN¥348.61 Million ≈ $51.01 Million |
CN¥57.72 Million ≈ $8.45 Million |
0.166x | -- |
About Zhejiang Medicine Co Ltd
Zhejiang Medicine Co., Ltd. manufactures and sells life nutrition and pharmaceuticals products in China and internationally. The company offers synthetic vitamin E, vitamin A, natural vitamin E, ß-carotene, canthaxanthin, vancomycin hydrochloride, teicoplanin, and daptomycin. It also provides fat-soluble vitamins, quinolone antibiotics, anti-drug-resistant antibiotics, and other products, as well… Read more